Scientific work

Prof. Dr. Ayşe Filiz Arpaçag Koşar

33 publications. The source of the information is stated next to each publication.

Back to profile

  1. A1. Altin S, Cikrikçioğlu S, Morgül M, Koşar F, Ozyurt H 50 endobronchial tuberculosis cases based on bronchoscopic diagnosis. Respiration. 1997;64 (2):162-4.

    Source: florence.com.tr profile page

  2. A2. Umut S, Tutluoğlu B, Tosun GA, Müsellim B, Erk M, Yıldırım N, Vahapoğlu H, Yılmaz N, Arseven O, Türker H, Erelel M, İlvan A, Goylusun V, Yılmaz V, Kuyucu T, Koşar F, Soysal F, Gür A, Unutmaz S, Öztürk S, Akman M Determination of the etiological organism durind acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society .COPD wörking group. J Chemother 1999 ;1(3): 211-4

    Source: florence.com.tr profile page

  3. A3. Çağatay T, Yurt S, Kıran B, Koşar F , Gülbaran Z, Çağatay P. Levels of TNF- and IL-1 in newly diagnosed and multidrug resistan tuberculosis. Respirology 2005; 10: 290-294 .

    Source: florence.com.tr profile page

  4. A4. Aydıner A, Kıyık M, Çıkrıkçıoğlu S , Koşar F, Gürses A , Turna A , Yazar A , Dilege Ş, Göksel T , Çakan A. Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study. Lung Cancer 2007; 58 (2) ; 246-52

    Source: florence.com.tr profile page

  5. A5. Vatansever S, Gelisgen R, Uzun H, Yurt S, Kosar F Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions. Clin Invest Med 2009; 32 (4): E293-E300

    Source: florence.com.tr profile page

  6. A6. Kiran B , Kosar F, Suzergoz F, Yurt S , Cagatay P , Cagatay T , Clark P , Gurol AO Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis? AMS 2010; 6 (1):77-82.

    Source: florence.com.tr profile page

  7. A7. Yurt S , Erman H , Korkmaz G.G, Kosar A.F, Uysal P, Gelisgen R, Simsek G, Uzun H. The role of feed regulating peptides on weight loss in patients with pulmonary tuberculosis Clinical Biochemistry ; 2013; 4: 640–44

    Source: florence.com.tr profile page

  8. A8. Sayar A, Çıtak N, Büyükkale S, Metin M, Günlüoğlu M Z, Kanbur S, Demir A, Dalar L, Özgül M A, Koşar F, Çıkrıkçıoğlu S, Gürses A. Sleeve karinal rezeksiyon ve rekonstrüksiyon: Malign tümörlerin karinal invazyonunun cerrahi endikasyonu ve sonuçları. Türk Göğüs Kalp Damar Cerrahisi Dergisi 2013;21(2):392-401

    Source: florence.com.tr profile page

  9. A9. Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators Tiotropium Respimat inhaler and the risk of death in COPD N Engl J Med. 2013 Oct 17;369(16):1491-501

    Source: florence.com.tr profile page

  10. A10. P Uysal, S Yurt, H Erman, GG Korkmaz, BA Yiğitbaş , F Koşar, H Uzun. The role of chitotriosidase activity as a prognostic biomarker in sarcoidosis . Acta Medica Mediterranea, 2015, 31: 1223

    Source: florence.com.tr profile page

  11. A11. Yiğitbaş B A, Yurt S, Koşar A F, Işık N, Karakaş E C, Özçelik H K, Ürer N. Primer akciğer karsinomu nedeniyle opere edilecek hastalarda otofloresan bronkoskopi ile prekanseröz lezyonların araştırılması . Tüberküloz ve Toraks 2013 ; 61 (2) : 122-13

    Source: florence.com.tr profile page

  12. A12. Yurt S, Küçükergin C, Yiğitbaş B.A, Seçkin Ş, Tigin H C, Koşar A F Diagnostic utility of serum and pleural levels of adenosine deaminase 1-2, and interferon- in the diagnosis of pleural effusions. Multidiciplinary Respiratory Medicine 2014; 9: 12

    Source: florence.com.tr profile page

  13. A13. Kekecoglu A, Dalar L, Omaygenc D O, Yigitbas B A, Ozenc E, Kosar F Intensive care in cases with thoracic and extrathoracic malignant solid tumours: Indications and survival Pneumon 2015, 28 (3): 222-229

    Source: florence.com.tr profile page

  14. A14. Koşar F, Yurt S, Yiğitbaş B A, Şeker B, Özçelik H K, Uzun H The comparative value of pleural fluid adenosine deaminase and neopterin levels in diagnostic utility of pleural tuberculosis Tüberküloz ve Toraks Cilt: 63 Sayı: 4 Yıl: 2015

    Source: florence.com.tr profile page

  15. A15. Koşar AF, Dalar L , Eryuksel E, Uysal P ,Akbaş T Kekecoğlu A Characteristics of Active Tuberculosis Patients Requiring Intensive Care Monitoring and Factors Affecting Mortality. Tuberc Respir Dis 2016;79:158-164

    Source: florence.com.tr profile page

  16. A16.Koşar F, Alici DE, Hacibedel B, Yigitbas BA, Golabi P, Cuhadaroglu Ç. Burden of community-acquired pneumonia in adults over 18 y of age. Human vaccınes & Immunotherapeutıcs 2017, vol. 13, no. 7, 1673–1680

    Source: florence.com.tr profile page

  17. A17: Celal Satici, Burcu Arpinar Yigitbas, Baris Seker, Mustafa Asim Demirkol & Ayse Filiz Kosar (2018): Does Adherence to Domiciliary NIMV Decrease the Subsequent Hospitalizations Rates and Cost for Patients Diagnosed with COPD?, COPD: Journal of Chronic Obstructive Pulmonary Disease

    Source: florence.com.tr profile page

  18. A18: Uysal P, Simsek G, Durmus S, Sozer V, Aksan H, Yurt S, Cuhadaroglu C, Kosar F, Gelisgen R, Uzun H. Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019 Jan 25;14:321-330.

    Source: florence.com.tr profile page

  19. A19: Şahin F, Koşar AF, Aslan AF, Yiğitbaş B, Uslu B. Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study. J Med Biochem. 2019 Jan 22;38(4):503-511

    Source: florence.com.tr profile page

  20. A20: Mediha Gönenç Ortaköylü, Sedat Altın, Ayşe Bahadır, Halide Nur Ürer, Filiz Koşar, Ali Coskun. Activity-Based Costing Management and Hospital Cost in Patients with Chronic Obstructive Pulmonary Disease Eur J Gen Med 2016;13(2):116-126

    Source: florence.com.tr profile page

  21. A21:Seker B, Yigitbas BA, Satici C, Yurt S, Kosar AF. The relationship of bronchiectasis to airway obstruction and inflammation in patients with chronic obstructive pulmonary disease.

    Source: florence.com.tr profile page

  22. A22: Gulbas, G, Turan, O, Sarioglu, N, et al. Carotid intima-media thickness in chronic obstructive pulmonary disease and survival: A multicenter prospective study. Clin Respir J. 2019; 13: 391– 399.

    Source: florence.com.tr profile page

  23. A23: Arpinar Yigitbas B, Satici C, Kosar AF. Adenosine deaminase cutoff value when diagnosing tuberculous pleurisy in patients aged 40 years and older. The Clinical Respiratory Journal. 2021 Jan;15(1):109-115.

    Source: florence.com.tr profile page

  24. A24: Celal Satici, Burcu Arpinar Yigitbas, Mustafa Asim Demirkol & A.Filiz Kosar

    Source: florence.com.tr profile page

  25. (2020): Determining emphysema in adult patients with COPD-Bronchiectasis overlap using a

    Source: florence.com.tr profile page

  26. novel spirometric parameter: area under the forced expiratory flow-volume loop, Expert Review of Respiratory Medicine, DOI: 10.1080/17476348.2020.1766972

    Source: florence.com.tr profile page

  27. A25: Satıcı C, Aydın Ş, Tuna L, Köybaşı G, Koşar F. Electromyographic and sonographic assessment of diaphragm dysfunction in patients who recovered from the COVID-19 pneumonia. Tuberk Toraks 2021;69(3):425-428

    Source: florence.com.tr profile page

  28. A26: Niksarlioglu EY, Yigitbas B, Çamsari G, Kosar F. Health related quality of life in elderly patients with bronchiectasis. Eurasian J Pulmonol 2020;22:98-103.

    Source: florence.com.tr profile page

  29. A27: ÇINARKA, HALİT; GÜNLÜOĞLU, GÜLŞAH; ÇÖRTÜK, MUSTAFA; YURT, SİBEL; KIYIK, MURAT; KOŞAR, AYŞE FİLİZ; TANRIVERDİ, ELİF; ARSLAN, MELİH AKAY; BAYDİLİ, KÜRŞAD NURİ; KOÇ, AYSU SİNEM; ALTIN, SEDAT; And ÇETİNKAYA, ERDOĞAN (2021) "The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19treatment," Turkish Journal of Medical Sciences: Vol. 51: No. 4, Article 3.

    Source: florence.com.tr profile page

  30. A28: YAZAR, ESRA; YİĞİTBAŞ, BURCU ARPINAR; ÖZTÜRK, CAN; ÇALIKOĞLU, MUKADDER; GÜLBAŞ, GAZİ; TURAN, MUZAFFER ONUR; ŞAHİN, HÜLYA DOĞAN; SARIOĞLU, NURHAN; HOCA, NEVİN TACİ; BOZKUŞ, FULSEN; ÖNÜR, SEDA TURAL; MİRİCİ, NİHAL ARZU; OGAN, NALAN; DEMİRCİ, NİLGÜN YILMAZ; and YORMAZ, BURCU (2022) "Chronic obstructive pulmonary disease phenotypes in Turkey: the COPET study-a national, multicenter cross-sectional observational study," Turkish Journal of Medical Sciences: Vol. 52: No. 4, Article 31.

    Source: florence.com.tr profile page

  31. A29: Yigitbas, B.A., Sibel, Y., Berat, U. et al. Relationship between platelet count, platelet indices, and inflammatory markers in stable and acute exacerbation of bronchiectasis patients. Egypt J Bronchol 12, 173–179 (2018)

    Source: florence.com.tr profile page

  32. A30: Erinc A, Ozcelik HK, Yigitbas BA, Yurt S, Kosar F. Does subglottic secretion drainage prevent ventilator-associated pneumonia? Eurasian J Pulmonol 2018;20:122-7

    Source: florence.com.tr profile page

  33. A31: Satici, C., Demirkol, M. A., Yigitbas, B. A., Erinc, A., & Kosar, A. F. (2021). Area under flow-volume loop may predict severe exacerbation in COPD patients with high grade of dyspnea. Respiratory Physiology & Neurobiology, 294, 103771.

    Source: florence.com.tr profile page